DarioHealth
DRIO
27 hedge funds and large institutions have $34M invested in DarioHealth in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
17% more capital invested
Capital invested by funds: $29.1M → $34M (+$4.83M)
13% more funds holding
Funds holding: 24 → 27 (+3)
0.26% more ownership
Funds ownership: 1.21% → 1.47% (+0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.18M |
| 2 |
FA
Friess Associates
Greenville,
Delaware
|
+$3.09M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.32M |
| 4 |
Renaissance Technologies
New York
|
+$494K |
| 5 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$411K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$3.39M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
-$340K |
| 3 |
IIA
IPG Investment Advisors
San Diego,
California
|
-$53.6K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$25K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$21.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $1K | -$5.41K | -21 | -91% |
|
|
TWM
27
Tradition Wealth Management
Edina,
Minnesota
| $1K | +$1.29K | +5 | New |
|
|
GIPM
28
G2 Investment Partners Management
New York
| – | -$340K | -1,012 | Closed |
|
|
29
Bank of America
Charlotte,
North Carolina
| – | -$21.9K | -85 | Closed |
|
|
S
30
SignatureFD
Atlanta,
Georgia
| – | -$25K | -73 | Closed |
|
DRIO Hedge Fund Activity: Q4 2020 in Review
27 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2020, worth a combined $34M — up 17% from $29.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DRIO positions and 3 closed out — a net gain of 3 holders — while 10 added to existing stakes and 4 trimmed.
The largest buyer was Soleus Capital Management, opening a new position worth an estimated $5.18M. The largest seller was Phoenix Financial, cutting an estimated $3.39M.
- 27 institutional investors held DarioHealth (DRIO) as of Q4 2020, up from 24 in Q3 2020.
- Funds reported $34M of DarioHealth stock for Q4 2020, up 17% quarter-over-quarter.
- 6 funds opened new DarioHealth positions in Q4 2020 and 3 closed out, a net change of +3 holders.
- The largest DarioHealth buyer in Q4 2020 was Soleus Capital Management, an estimated $5.18M added.
- The largest DarioHealth seller in Q4 2020 was Phoenix Financial, an estimated $3.39M sold.
Based on aggregated 13F filings for Q4 2020.